Cargando…

Differential Role of PKC-Induced c-Jun in HTLV-1 LTR Activation by 12-O-Tetradecanoylphorbol-13-acetate in Different Human T-cell Lines

We have previously shown that TPA activates HTLV-1 LTR in Jurkat T-cells by inducing the binding of Sp1-p53 complex to the Sp1 site residing within the Ets responsive region 1 (ERR-1) of the LTR and that this activation is inhibited by PKCalpha and PKCepsilon. However, in H9 T-cells TPA has been not...

Descripción completa

Detalles Bibliográficos
Autores principales: Abou-Kandil, Ammar, Chamias, Rachel, Huleihel, Mahmoud, Godbey, W. T., Aboud, Mordechai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267723/
https://www.ncbi.nlm.nih.gov/pubmed/22299029
http://dx.doi.org/10.1371/journal.pone.0029934
_version_ 1782222313981214720
author Abou-Kandil, Ammar
Chamias, Rachel
Huleihel, Mahmoud
Godbey, W. T.
Aboud, Mordechai
author_facet Abou-Kandil, Ammar
Chamias, Rachel
Huleihel, Mahmoud
Godbey, W. T.
Aboud, Mordechai
author_sort Abou-Kandil, Ammar
collection PubMed
description We have previously shown that TPA activates HTLV-1 LTR in Jurkat T-cells by inducing the binding of Sp1-p53 complex to the Sp1 site residing within the Ets responsive region 1 (ERR-1) of the LTR and that this activation is inhibited by PKCalpha and PKCepsilon. However, in H9 T-cells TPA has been noted to activate the LTR in two consecutive stages. The first stage is activation is mediated by PKCetta and requires the three 21 bp TRE repeats. The second activation mode resembles that of Jurkat cells, except that it is inhibited by PKCdelta. The present study revealed that the first LTR activation in H9 cells resulted from PKCetta-induced elevation of non-phosphorylated c-Jun which bound to the AP-1 site residing within each TRE. In contrast, this TRE-dependent activation did not occur in Jurkat cells, since there was no elevation of non-phosphorylated c-Jun in these cells. However, we found that PKCalpha and PKCepsilon, in Jurkat cells, and PKCetta and PKCdelta, in H9 cells, increased the level of phosphorylated c-Jun that interacted with the Sp1-p53 complex. This interaction prevented the Sp1-p53 binding to ERR-1 and blocked, thereby, the ERR-1-mediated LTR activation. Therefore, this PKC-inhibited LTR activation started in both cell types after depletion of the relevant PKCs by their downregulation. In view of these variable activating mechanisms we assume that there might be additional undiscovered yet modes of HTLV-1 LTR activation which vary in different cell types. Moreover, in line with this presumption we speculate that in HTLV-1 carriers the LTR of the latent provirus may also be reactivated by different mechanisms that vary between its different host T-lymphocyte subclones. Since this reactivation may initiate the ATL process, understanding of these mechanisms is essential for establishing strategies to block the possibility of reactivating the latent virus as preventive means for ATL development in carriers.
format Online
Article
Text
id pubmed-3267723
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-32677232012-02-01 Differential Role of PKC-Induced c-Jun in HTLV-1 LTR Activation by 12-O-Tetradecanoylphorbol-13-acetate in Different Human T-cell Lines Abou-Kandil, Ammar Chamias, Rachel Huleihel, Mahmoud Godbey, W. T. Aboud, Mordechai PLoS One Research Article We have previously shown that TPA activates HTLV-1 LTR in Jurkat T-cells by inducing the binding of Sp1-p53 complex to the Sp1 site residing within the Ets responsive region 1 (ERR-1) of the LTR and that this activation is inhibited by PKCalpha and PKCepsilon. However, in H9 T-cells TPA has been noted to activate the LTR in two consecutive stages. The first stage is activation is mediated by PKCetta and requires the three 21 bp TRE repeats. The second activation mode resembles that of Jurkat cells, except that it is inhibited by PKCdelta. The present study revealed that the first LTR activation in H9 cells resulted from PKCetta-induced elevation of non-phosphorylated c-Jun which bound to the AP-1 site residing within each TRE. In contrast, this TRE-dependent activation did not occur in Jurkat cells, since there was no elevation of non-phosphorylated c-Jun in these cells. However, we found that PKCalpha and PKCepsilon, in Jurkat cells, and PKCetta and PKCdelta, in H9 cells, increased the level of phosphorylated c-Jun that interacted with the Sp1-p53 complex. This interaction prevented the Sp1-p53 binding to ERR-1 and blocked, thereby, the ERR-1-mediated LTR activation. Therefore, this PKC-inhibited LTR activation started in both cell types after depletion of the relevant PKCs by their downregulation. In view of these variable activating mechanisms we assume that there might be additional undiscovered yet modes of HTLV-1 LTR activation which vary in different cell types. Moreover, in line with this presumption we speculate that in HTLV-1 carriers the LTR of the latent provirus may also be reactivated by different mechanisms that vary between its different host T-lymphocyte subclones. Since this reactivation may initiate the ATL process, understanding of these mechanisms is essential for establishing strategies to block the possibility of reactivating the latent virus as preventive means for ATL development in carriers. Public Library of Science 2012-01-27 /pmc/articles/PMC3267723/ /pubmed/22299029 http://dx.doi.org/10.1371/journal.pone.0029934 Text en Abou-Kandil et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Abou-Kandil, Ammar
Chamias, Rachel
Huleihel, Mahmoud
Godbey, W. T.
Aboud, Mordechai
Differential Role of PKC-Induced c-Jun in HTLV-1 LTR Activation by 12-O-Tetradecanoylphorbol-13-acetate in Different Human T-cell Lines
title Differential Role of PKC-Induced c-Jun in HTLV-1 LTR Activation by 12-O-Tetradecanoylphorbol-13-acetate in Different Human T-cell Lines
title_full Differential Role of PKC-Induced c-Jun in HTLV-1 LTR Activation by 12-O-Tetradecanoylphorbol-13-acetate in Different Human T-cell Lines
title_fullStr Differential Role of PKC-Induced c-Jun in HTLV-1 LTR Activation by 12-O-Tetradecanoylphorbol-13-acetate in Different Human T-cell Lines
title_full_unstemmed Differential Role of PKC-Induced c-Jun in HTLV-1 LTR Activation by 12-O-Tetradecanoylphorbol-13-acetate in Different Human T-cell Lines
title_short Differential Role of PKC-Induced c-Jun in HTLV-1 LTR Activation by 12-O-Tetradecanoylphorbol-13-acetate in Different Human T-cell Lines
title_sort differential role of pkc-induced c-jun in htlv-1 ltr activation by 12-o-tetradecanoylphorbol-13-acetate in different human t-cell lines
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267723/
https://www.ncbi.nlm.nih.gov/pubmed/22299029
http://dx.doi.org/10.1371/journal.pone.0029934
work_keys_str_mv AT aboukandilammar differentialroleofpkcinducedcjuninhtlv1ltractivationby12otetradecanoylphorbol13acetateindifferenthumantcelllines
AT chamiasrachel differentialroleofpkcinducedcjuninhtlv1ltractivationby12otetradecanoylphorbol13acetateindifferenthumantcelllines
AT huleihelmahmoud differentialroleofpkcinducedcjuninhtlv1ltractivationby12otetradecanoylphorbol13acetateindifferenthumantcelllines
AT godbeywt differentialroleofpkcinducedcjuninhtlv1ltractivationby12otetradecanoylphorbol13acetateindifferenthumantcelllines
AT aboudmordechai differentialroleofpkcinducedcjuninhtlv1ltractivationby12otetradecanoylphorbol13acetateindifferenthumantcelllines